157 related articles for article (PubMed ID: 17352520)
1. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Yoon-Koo Kang.
Kang YK
Drugs; 2007; 67(4):611-2. PubMed ID: 17352520
[No Abstract] [Full Text] [Related]
2. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
Ou SH; Holcombe RF
Drugs; 2007; 67(4):611-2. PubMed ID: 17352521
[No Abstract] [Full Text] [Related]
3. Capecitabine: in advanced gastric or oesophagogastric cancer.
Dhillon S; Scott LJ
Drugs; 2007; 67(4):601-10. PubMed ID: 17352519
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine in advanced gastric cancer.
Okines A; Chau I; Cunningham D
Expert Opin Pharmacother; 2007 Nov; 8(16):2851-61. PubMed ID: 17956204
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine in gastric cancer.
Bang YJ
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1791-806. PubMed ID: 22117147
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine.
Schellens JH
Oncologist; 2007 Feb; 12(2):152-5. PubMed ID: 17296810
[No Abstract] [Full Text] [Related]
7. Capecitabine in gastric cancer.
Okines A; Chau I; Cunningham D
Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
[TBL] [Abstract][Full Text] [Related]
8. Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.
Chong G; Cunningham D
Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):79-80. PubMed ID: 15830568
[No Abstract] [Full Text] [Related]
9. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
10. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
Ajani J
Cancer; 2006 Jul; 107(2):221-31. PubMed ID: 16770784
[TBL] [Abstract][Full Text] [Related]
11. X-ACT: an important step on an unfinished journey.
Maughan T
Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
[No Abstract] [Full Text] [Related]
12. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma.
Carstens H; Albertsson M
Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915
[No Abstract] [Full Text] [Related]
13. [Capecitabine in the treatment of colorectal cancer].
Zeuli M; Pino MS; Cognetti F
Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027
[No Abstract] [Full Text] [Related]
14. Capecitabine induced colitis.
Maggo G; Grover SC; Grin A
Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
[TBL] [Abstract][Full Text] [Related]
15. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
16. Oral treatment for gastric cancer: new choices, better choices?
Cascinu S
Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
[No Abstract] [Full Text] [Related]
17. Emerging role of capecitabine in gastric cancer.
Comella P; Franco L; Casaretti R; de Portu S; Menditto E
Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.
Saif MW; Shi N; Zelt S
World J Gastroenterol; 2009 Sep; 15(35):4415-22. PubMed ID: 19764093
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.
Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064
[No Abstract] [Full Text] [Related]
20. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
Bel B; Lorton MH; Darut-Jouve A; Vabres P
Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
[No Abstract] [Full Text] [Related]
[Next] [New Search]